Alpine Immune Sciences Prices $150M Public Offering Of 8.8M Common shares At $12.50/Share
Portfolio Pulse from Benzinga Newsdesk
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) has priced its underwritten public offering of 8.8 million shares of its common stock at $12.50 per share. In addition, the company is offering pre-funded warrants to purchase up to 3.2 million shares of its common stock at a price of $12.499 per pre-funded warrant.
November 07, 2023 | 7:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alpine Immune Sciences' public offering and pre-funded warrants could potentially dilute existing shareholders' equity, which may negatively impact the stock price in the short term.
Public offerings often lead to dilution of existing shareholders' equity, which can result in a decrease in the stock price. The impact is more significant if the offering price is lower than the current market price. In this case, the offering price is $12.50 per share, which may or may not be lower than the current market price. The pre-funded warrants also add to the potential dilution.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100